---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007004"
form_type: "8-K"
ticker: "NEPH"
cik: "0001196298"
company_name: "NEPHROS INC"
filed_at: "2023-03-08T23:59:59+00:00"
generated_at: "2026-06-18T08:14:43.061096+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Nephros reports FY2022 net revenue $10M; net loss widens to $4.3M; subsidiary SRP winding down

## Summary
- Net revenue from continuing operations: $10.0M in FY2022 (-2% YoY); Q4 $2.6M (-6% YoY).
- Net loss from continuing operations: $4.3M in FY2022 vs $2.8M loss in 2021; Q4 loss $0.7M flat.
- Gross margins improved to 59% in Q4 (vs 54% prior year); full-year margins 47% (vs 55%).
- Majority-owned subsidiary SRP to wind down after failing to find strategic partner; expects cessation in Q2 2023.
- Cash and equivalents $3.6M at Dec 31, 2022; targeting cash flow breakeven by mid-2023.

## SEC filing metadata
- accession: 0001493152-23-007004
- form_type: 8-K
- ticker: NEPH
- cik: 0001196298
- company_name: NEPHROS INC
- filed_at: 2023-03-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/0001493152-23-007004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007004
- JSON: https://secwatch.observer/filing/0001493152-23-007004.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007004.txt

## Key facts
- Earnings Releases
  NEPHROS INC reported fourth quarter and fiscal year ended December 31, 2022 results: revenue $2.6 million (Q4); $10.0 million (FY), net income ($0.7 million) (Q4); ($4.3 million) (FY).
  - Period: fourth quarter and fiscal year ended December 31, 2022
  - Revenue: $2.6 million (Q4); $10.0 million (FY)
  - Net income: ($0.7 million) (Q4); ($4.3 million) (FY)
  - Result: reported results
  source text: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results Full-Year Net Revenue of $10 Million and Fourth Quarter Net Revenue of $2.6 Million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1196298/000149315223007004/0001493152-23-007004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.